| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008787406 |
| P356 | DOI | 10.1186/1471-2458-12-398 |
| P932 | PMC publication ID | 3560211 |
| P698 | PubMed publication ID | 22657090 |
| P5875 | ResearchGate publication ID | 225093840 |
| P50 | author | Linda Cobiac | Q91736847 |
| Theo Vos | Q28468981 | ||
| P2093 | author name string | Rob Carter | |
| Jan J Barendregt | |||
| Anne Magnus | |||
| P2860 | cites work | Statins for the primary prevention of cardiovascular disease | Q24234813 |
| Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials | Q24645391 | ||
| The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials | Q24646234 | ||
| Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies | Q24658205 | ||
| Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? | Q33523245 | ||
| Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials | Q33767211 | ||
| Discontinuation rates for use of statins are high | Q33802638 | ||
| Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial | Q34021483 | ||
| Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study | Q34683640 | ||
| Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles | Q34734618 | ||
| Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials | Q35107962 | ||
| Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs | Q37026080 | ||
| Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina | Q37197082 | ||
| A systematic review and meta-analysis on the therapeutic equivalence of statins | Q37747986 | ||
| An alternative approach to projecting health expenditure in Australia | Q40128139 | ||
| Estimates of global and regional potential health gains from reducing multiple major risk factors | Q40571153 | ||
| Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS). | Q43580548 | ||
| Stroke incidence on the east coast of Australia: the North East Melbourne Stroke Incidence Study (NEMESIS). | Q43990132 | ||
| Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk | Q44350190 | ||
| Persistence with antihypertensive medication: Australia-wide experience, 2004-2006. | Q46750765 | ||
| Combination polypharmacy for cardiovascular disease prevention in men: a decision analysis and cost-effectiveness model | Q46823637 | ||
| The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors | Q50126848 | ||
| Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. | Q51914599 | ||
| Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure. | Q51929762 | ||
| Cardiovascular disease risk profiles. | Q52461317 | ||
| Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors. | Q54074080 | ||
| Multivariate risk estimation for coronary heart disease: the Busselton Health Study | Q61696457 | ||
| Risk factors for stroke mortality in men and women: The Busselton Study | Q73106142 | ||
| The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit | Q74106840 | ||
| Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996) | Q77327675 | ||
| Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia | Q83748347 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Australia | Q408 |
| cardiovascular disease | Q389735 | ||
| cost-effectiveness analysis | Q1754768 | ||
| disease prevention | Q106807541 | ||
| P304 | page(s) | 398 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | BMC Public Health | Q15767009 |
| P1476 | title | Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study | |
| P478 | volume | 12 |
| Q36181499 | Assessing the external validity of model-based estimates of the incidence of heart attack in England: a modelling study |
| Q30843316 | Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data |
| Q47802987 | Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis |
| Q42376823 | Cost-effectiveness of stroke care in Aboriginal and non-Aboriginal patients: an observational cohort study in the Northern Territory of Australia. |
| Q59792283 | Economic evaluation of the NET intervention versus guideline dissemination for management of mild head injury in hospital emergency departments |
| Q92229486 | Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study |
| Q36013827 | Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China |
| Q57313010 | Evidence-to-practice gaps in post-stroke management: a focus on care in a stroke unit and anticoagulation to prevent death, disability and recurrent stroke |
| Q54869175 | Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention. |
| Q92989516 | Implementing cardiovascular disease prevention guidelines to translate evidence-based medicine and shared decision making into general practice: theory-based intervention development, qualitative piloting and quantitative feasibility |
| Q37306497 | Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature. |
| Q92162898 | Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk |
| Q35671763 | Salt reduction in Australia: from advocacy to action |
| Q47613877 | The potential health and economic impact of improving stroke care standards for Australia |
Search more.